Perspective Therapeutics (NYSE:CATX) Stock Price Expected to Rise, B. Riley Analyst Says
Perspective Therapeutics (NYSE:CATX – Get Free Report) had its price target lifted by investment analysts at B. Riley from $9.00 to $12.00 in a research note issued on Monday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. B. Riley’s price target would indicate a potential upside of 214.14% from the stock’s current […]
